Fol. Biol. 2007, 53, 1-6
https://doi.org/10.14712/fb2007053010001
Transcription Protein STAT1: Biology and Relation to Cancer
References
1. , S. (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17, 138-146.
<https://doi.org/10.1002/stem.170138>
2. , N., Matsuda, T. (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 16, 58-69.
<https://doi.org/10.1210/mend.16.1.0761>
3. , T. E., Frank, D. A. (2002) The role of STATs in apoptosis. Curr. Mol. Med. 2, 381-392.
<https://doi.org/10.2174/1566524023362456>
4. , V., Kocak, I., Lauerova, L., Kovarik, J. (2003) Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients. Folia Biol. (Praha) 49, 142-146.
5. , V., Dusek, L., Adamkova, L., Chumchalova, J., Kocak, I., Fait, V., Lauerova, L., Krejci, E., Kovarik, J. (2005) Lack of STAT 1 phosphorylation at TYR 701 by IFNγ correlates with disease outcome in melanoma patients. Neoplasma 52, 330-337.
6. , T., Garcia, R., Turkson, J., Jove, R. (2000) STATs in oncogenesis. Oncogene 19, 2474-2488.
<https://doi.org/10.1038/sj.onc.1203527>
7. , J., Kohlhuber, F., Muller, M. (1996) JAKs and STATs branch out. Trends Cell Biol. 6, 336-340.
<https://doi.org/10.1016/0962-8924(96)10028-3>
8. , J. F. (2001) Activation of STAT proteins and growth control. BioEssays 23, 161-169.
<https://doi.org/10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0>
9. , J., Darnell, J. E. Jr. (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
<https://doi.org/10.1038/sj.onc.1203476>
10. , J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., Darnell, J. E. Jr. (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA 93, 7673-7678.
<https://doi.org/10.1073/pnas.93.15.7673>
11. , J. F., Fan, Z., Brown, C., Mendelsohn, J., Darnell, J. E. Jr. (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9, 505-512.
12. , R., Mora, L. B., Jove, R. (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8, 945-954.
13. , T. L., Peng, X., Fu, X. Y. (2000) Interleukin-4 mediates cell growth inhibition through activation of Stat1. J. Biol. Chem. 275, 10212-10217.
<https://doi.org/10.1074/jbc.275.14.10212>
14. , M., Wright, K. L., Ting, J. P., Stark, G. R. (2000) How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19, 4111-4122.
<https://doi.org/10.1093/emboj/19.15.4111>
15. , Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y., Fu, X. Y. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272, 719-722.
<https://doi.org/10.1126/science.272.5262.719>
16. , J. E. Jr., Kerr, I. M., Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
<https://doi.org/10.1126/science.8197455>
17. , A. S., van de Loo, F. A., Koenders, M. I., Bennink, M. B., Arntz, O. J., Kolbe, T., van den Berg, W. B. (2004) Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum. 50, 2014-2023.
<https://doi.org/10.1002/art.20302>
18. , J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
<https://doi.org/10.1016/S0092-8674(00)81289-1>
19. , J. E., Fernandez-Sesma, A., Lee, C. K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., Garcia-Sastre, A., Levy, D. E. (2000) Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220-4228.
<https://doi.org/10.4049/jimmunol.164.8.4220>
20. , S. E., Bertone, P., Nath, A. K., Royce, T. E., Gerstein, M., Weissman, S., Snyder, M. (2005) Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 19, 2953-2968.
<https://doi.org/10.1101/gad.1371305>
21. , Y. Q., Li, J. J., Karpatkin, S. (2000) Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT1-dependent pathway. J. Biol. Chem. 275, 6462-6468.
<https://doi.org/10.1074/jbc.275.9.6462>
22. , J. N., Kerr, I. M. (1995) Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 6974.
<https://doi.org/10.1016/S0168-9525(00)89000-9>
23. , H., Old, L. J., Schreiber, R. D. (2002) The roles of IFN γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13, 95-109.
<https://doi.org/10.1016/S1359-6101(01)00038-7>
24. , L. B., Hu, X. (2004) Signaling by STATs. Arthritis Res. Ther. 6, 159-168.
<https://doi.org/10.1186/ar1197>
25. , S., Stephanou, A., Latchman, D. S. (2002) The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ. 9, 1140-1146.
<https://doi.org/10.1038/sj.cdd.4401082>
26. , D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., Schreiber, R. D. (1998) Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
<https://doi.org/10.1073/pnas.95.13.7556>
27. , M., Adachi, Y., Sogo, S., Taketani, S., Oyaizu, N., Than, S., Inaba, M., Phawa, S., Hioki, K., Ikehara, S. (1998) Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-α (TNF-α) and/or interferon-γ (IFN-γ), resulting from down-modulation of Bcl-2 expression. Clin. Exp. Immunol. 111, 211-218.
<https://doi.org/10.1046/j.1365-2249.1998.00460.x>
28. , A., Fojtova, M., Boudny, V., Adamkova, L., Lauerova, L., Kovarik, J. (2005) Interferon γ but not α induce SOCS 3 expression of human melanoma cell lines. Melanoma Res. 15, 481-488.
<https://doi.org/10.1097/00008390-200512000-00001>
29. , J., Boudny, V., Kocak, I., Lauerova, L., Fait, V., Vagundova, M. (2003) Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int. J. Mol. Med. 12, 335-340.
30. , P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D. E., Muller, M., Decker, T. (2001) Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20, 91-100.
<https://doi.org/10.1093/emboj/20.1.91>
31. , A., Commane, M., Flickinger, T. W., Horvath, C. M., Stark, G. R. (1997) Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278, 1630-1632.
<https://doi.org/10.1126/science.278.5343.1630>
32. , C. K., Rao, D. T., Gertner, R., Gimeno, R., Frey, A. B., Levy, D. E. (2000a) Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165, 3571-3577.
<https://doi.org/10.4049/jimmunol.165.7.3571>
33. , C. K., Smith, E., Gimeno, R., Gertner, R., Levy, D. E. (2000b) STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164, 1286-1292.
<https://doi.org/10.4049/jimmunol.164.3.1286>
34. , S. J., Zhou, T., Choi, C., Wang, Z., Benveniste, E. N. (2000c) Differential regulation and function of Fas expression on glial cells. J. Immunol. 164, 1277-1285.
<https://doi.org/10.4049/jimmunol.164.3.1277>
35. , D. E., Gilliland, D. G. (2000) Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19, 2505-2510.
<https://doi.org/10.1038/sj.onc.1203480>
36. , R., Euskirchen, G., Bertone, P., Hartman, S., Royce, T. E., Luscombe, N. M., Rinn, J. L., Nelson, F. K., Miller, P., Gerstein, M., Weissman, S., Snyder, M. (2003) Distribution of NF-κB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 100, 12247-12252.
<https://doi.org/10.1073/pnas.2135255100>
37. , E., El-Shafei, M., Maulik, N., Sato, M., Guo, Y., Das, D. K., Siddiqui, M. A. (2001) JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104, 325-329.
<https://doi.org/10.1161/01.CIR.104.3.325>
38. , M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAKSTAT signaling pathway. Cell 84, 431-442.
<https://doi.org/10.1016/S0092-8674(00)81288-X>
39. , M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E. Jr, Stark, G. R., Kerr, I. M. (1993) Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12, 4221-4228.
<https://doi.org/10.1002/j.1460-2075.1993.tb06106.x>
40. , T., Fujimoto, M., Kishimoto, T. (1999) Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem. Sci. 24, 394-398.
<https://doi.org/10.1016/S0968-0004(99)01454-1>
41. , T., Tanabe, Y., Su, L., David, M. (2004) Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199, 25-34.
<https://doi.org/10.1084/jem.20020509>
42. , N. K., Cannas, A., Powers, V. C., Fitzpatrick, P. A., Knight, J. D., Gilbert, J. R., Shekhtman, E. M., Tomei, L. D., Umansky, S. R., Kiefer, M. C. (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272, 16351-16357.
<https://doi.org/10.1074/jbc.272.26.16351>
43. , A., Hildebrand, P., Fasler-Kan, E., Baselgia, L., Ketterer, S., Beglinger, C., Heim, M. H. (2000) Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-α. Int. J. Cancer 85, 720-725.
<https://doi.org/10.1002/(SICI)1097-0215(20000301)85:5<720::AID-IJC20>3.0.CO;2-O>
44. , C. V., Chatterjee-Kishore, M., Nguyen, H., Stark, G. R. (2000) Complex roles of Stat1 in regulating gene expression. Oncogene 19, 2619-2627.
<https://doi.org/10.1038/sj.onc.1203525>
45. , M., Raz, R., Coffin, J. D., Levy, D., Basilico, C. (2001) STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128, 2119-2129.
<https://doi.org/10.1242/dev.128.11.2119>
46. , C., Fu, X. Y., Improta, T., Aebersold, R., Darnell, J. E. Jr. (1992) Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon α. Proc. Natl. Acad. Sci. USA 89, 7836-7839.
<https://doi.org/10.1073/pnas.89.16.7836>
47. , H. M., Milocco, L. H., Lamb, P., Darnell, J. E. Jr., Stein, R. B., Rosen, J. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041-3045.
<https://doi.org/10.1073/pnas.92.7.3041>
48. , V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., Schreiber, R. D. (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111.
<https://doi.org/10.1038/35074122>
49. , E. C., Ahn, J. M., Kim, C. H., Choi, Y., Ahn, Y. S., Kim, H., Kim, S. J., Park, J. H. (2001) IFN-γ induces cell death in human hepatoma cells through a TRAIL/death receptormediated apoptotic pathway. Int. J. Cancer 93, 262-268.
<https://doi.org/10.1002/ijc.1310>
50. , K. (1999) The STAT family of proteins in cytokine signaling. Prog. Biophys. Mol. Biol. 71, 405-422.
<https://doi.org/10.1016/S0079-6107(98)00051-0>
51. , K. (2000) Modulation of STAT signaling by STATinteracting proteins. Oncogene 19, 2638-2644.
<https://doi.org/10.1038/sj.onc.1203522>
52. , K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., Darnell, J. E. (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366, 580-583.
<https://doi.org/10.1038/366580a0>
53. , G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
<https://doi.org/10.1146/annurev.biochem.67.1.227>
54. , R., Hilton, D. J. (1999) Negative regulation of the JAK/STAT pathway. BioEssays 21, 47-52.
<https://doi.org/10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N>
55. , A., Brar, B. K., Scarabelli, T. M., Jonassen, A. K., Yellon, D. M., Marber, M. S., Knight, R. A., Latchman, D. S. (2000) Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J. Biol. Chem. 275, 10002-10008.
<https://doi.org/10.1074/jbc.275.14.10002>
56. , A., Latchman, D. S. (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23, 177-182.
<https://doi.org/10.1080/08977190500178745>
57. , W. C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., Fu, X. Y. (1997) Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288-292.
<https://doi.org/10.1038/386288a0>
58. , K., Kim, S., Kim, Y. H., Kim, K. A., Chang, I., Yagita, H., Shong, M., Lee, M. S. (2001) IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic β cell death. J. Immunol. 166, 4481-4489.
<https://doi.org/10.4049/jimmunol.166.7.4481>
59. , H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., Wagner, E. F., Taniguchi, T. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749.
<https://doi.org/10.1038/416744a>
60. , K., Akira, S. (2000) STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11, 199-207.
<https://doi.org/10.1016/S1359-6101(00)00005-8>
61. , J., de Jesus Ibarra-Sanchez, M., Fu, Y., Zhu, W., Tremblay, M., David, M., Shuai, K. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22, 5662-5668.
<https://doi.org/10.1128/MCB.22.16.5662-5668.2002>
62. , M., Finnegan, C. E., Rogers, K. M., Purcell, J. W., Trimble, A., Johnston, P. G., Boland, M. P. (2004) STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res. 64, 8357-8364.
<https://doi.org/10.1158/0008-5472.CAN-04-1864>
63. Timofeeva, O. A., Plisov, S., Evseev, A. A., Peng, S., JoseKampfner, M., Lovvorn, H. N., Dome, J. S., Perantoni, A. O. (2006) Serine-phosphorylated STAT1 is a prosurvival factor in Wilms’ tumor pathogenesis. Oncogene 25.
<https://doi.org/10.1038/sj.onc.1209742>
64. , P. A., Scarabelli, T. M., Davidson, S. M., Knight, R. A., Latchman, D. S., Stephanou, A. (2004) STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J. Biol. Chem. 279, 5811-5820.
<https://doi.org/10.1074/jbc.M302637200>
65. , A., Tonko-Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., Doppler, W. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin. Cancer Res. 8, 3065-3074.
66. , L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., Ralph, S. J. (1997) Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J. Biol. Chem. 272, 28779-28785.
<https://doi.org/10.1074/jbc.272.45.28779>
67. , S., Hilton, D. J., Smyth, G. K., Speed, T. P. (2006a) Proximal genomic localization of STAT1 binding and regulated transcriptional activity. BMC Genomics 7, 254.
<https://doi.org/10.1186/1471-2164-7-254>
68. , S., Zhang, J. G., Krebs, D. L., Mielke, L. A., Silver, J., Alexander, W. S., Speed, T. P., Nicola, N. A., Hilton, D. J. (2006b) The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281, 11135-11143.
<https://doi.org/10.1074/jbc.M509595200>
69. , Z., Baer, M. R., Block, A. W., Baumann, H., Wetzler, M. (1998) Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res. 58, 3173-3180.
70. , X., Fu, X. Y., Plate, J., Chong, A. S. (1998) IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58, 2832-2837.
71. , M., Yu, D. H., Feng, G. S. (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferonstimulated Jak/STAT pathway. Mol. Cell. Biol. 19, 2416-2424.
<https://doi.org/10.1128/MCB.19.3.2416>
